Pfizer secures FDA approval for Litfulo to treat severe Alopecia areata
Litfulo is said to be the first and only treatment approved by the FDA for adolescents with severe…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Jun 23
Litfulo is said to be the first and only treatment approved by the FDA for adolescents with severe…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
26 Jun 23
Additionally, Brii Bio will acquire exclusive global rights for the development and commercialisation of the novel lipopeptide BRII-693…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
23 Jun 23
The partnership is intended to combine Prime Medicine’s Prime Editing platform with Cimeio Therapeutics’ Shielded Cell and Immunotherapy…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
21 Jun 23
Dice Therapeutics leverages the Delscape technology platform to develop novel oral therapeutic candidates, including oral IL-17 inhibitors to…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
19 Jun 23
With this development, Prometheus now operates as a fully-owned subsidiary of Merck, and the common stock of Prometheus…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
16 Jun 23
According to the medical technology company, the trial is expected to use F-CD8 targeted imaging radiopharmaceutical to detect…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
16 Jun 23
The acquisition presents exciting opportunities for accelerated growth as it expands Rosemont's portfolio and grants access to new…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
15 Jun 23
Blue Water will acquire Zontivity, Trezix, Nalfon, Conjupri, Otovel and Cetraxal, which are approved by the US Food…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
15 Jun 23
CAL02 is a non-biological bacterial virulence neutraliser and anti-infective agent intended to treat severe community-acquired bacterial pneumonia as…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
14 Jun 23
The off-the-shelf packaging plasmids will also support the development of cell and gene therapies by offering quick availability,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates